111 related articles for article (PubMed ID: 12433050)
1. A novel route to radioiodinated [123I]-N-succinimidyl-3-iodobenzoate, a reagent for radioiodination of bioactive peptides.
Al-Jammaz I; Al-Otaibi B; Amartey JK
Appl Radiat Isot; 2002 Nov; 57(5):743-7. PubMed ID: 12433050
[TBL] [Abstract][Full Text] [Related]
2. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR
Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039
[TBL] [Abstract][Full Text] [Related]
3. Optimization of a convenient route to produce N-succinimidyl 4-radiodobenzoate for radioiodination of proteins.
Araujo EB; Santos JS; Colturato MT; Muramoto E; Silva CP
Appl Radiat Isot; 2003 Jun; 58(6):667-73. PubMed ID: 12798375
[TBL] [Abstract][Full Text] [Related]
4. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
[TBL] [Abstract][Full Text] [Related]
5. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
Vaidyanathan G; Zalutsky MR
Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
[TBL] [Abstract][Full Text] [Related]
6. Influence of prosthetic radioiodination on the chemical and biological behavior of chemotactic peptides labeled at high specific activity.
Pozzi OR; Sajaroff EO; Edreira MM
Appl Radiat Isot; 2006 Jun; 64(6):668-76. PubMed ID: 16483785
[TBL] [Abstract][Full Text] [Related]
7. Radioiodination of proteins using prosthetic group: a convenient way to produce labelled proteins with in vivo stability.
Santos JS; Muramoto E; Colturato MT; Siva CP; Araújo EB
Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):735-9. PubMed ID: 12619967
[TBL] [Abstract][Full Text] [Related]
8. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of dendrimer-based biotin radiopharmaceuticals to enhance whole-body clearance.
Sato N; Park CW; Kim HS; Han ES; Wong KJ; Paik RS; Park LS; Yao Z; Carrasquillo JA; Paik CH
Nucl Med Biol; 2003 Aug; 30(6):617-25. PubMed ID: 12900287
[TBL] [Abstract][Full Text] [Related]
10. N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualization.
Choi J; Vaidyanathan G; Koumarianou E; McDougald D; Pruszynski M; Osada T; Lahoutte T; Lyerly HK; Zalutsky MR
Nucl Med Biol; 2014; 41(10):802-12. PubMed ID: 25156548
[TBL] [Abstract][Full Text] [Related]
11. Prosthetic radioiodination of interleukin-8 ([(123/131)I]-IL-8): biological behavior in a mouse infection model.
Amartey JK; Esguerra C; Al-Otaibi B; Al-Jammaz I; Al-Qahtani M; Parhar RS
Appl Radiat Isot; 2005 Jan; 62(1):39-47. PubMed ID: 15498683
[TBL] [Abstract][Full Text] [Related]
12. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
[TBL] [Abstract][Full Text] [Related]
13. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(4):269-73. PubMed ID: 2096920
[TBL] [Abstract][Full Text] [Related]
14. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
Garg PK; Slade SK; Harrison CL; Zalutsky MR
Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522
[TBL] [Abstract][Full Text] [Related]
15. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
16. An efficient batch preparation of high specific activity.
Amartey JK; Al-Jammaz I; Lambrecht RM
Appl Radiat Isot; 2001 May; 54(5):711-4. PubMed ID: 11258518
[TBL] [Abstract][Full Text] [Related]
17. A facile method for post-conjugation prosthetic radioiodination of "mini-peptides".
Amartey JK; Esguerra C
Appl Radiat Isot; 2006 Dec; 64(12):1549-54. PubMed ID: 16300955
[TBL] [Abstract][Full Text] [Related]
18. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
19. Radioiodination and biodistribution of quantum dots using Bolton-Hunter reagent.
Park JJ; Lee TS; Kang JH; Song R; Cheon GJ
Appl Radiat Isot; 2011 Jan; 69(1):56-62. PubMed ID: 20888778
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
